Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
ConditionNAFLD
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAin Shams University
About this trial
evaluate the combined effects of Rutin and Vitamin C versus Vitamin C alone on selected oxidative stress markers, inflammation, hepatic steatosis regression, and associated metabolic parameters in patients with MASLD
Eligibility criteria
Qualifiers
Confirmed diagnosis of Metabolic-Associated Steatotic Liver Disease (MASLD).
Disqualifiers
HCV infection.
HBV infection.
Patients with a history of significant alcohol consumption.
Autoimmune hepatitis.
Trial design
Treatments tested in this trial
- Rutin + Vitamin C
- Vitamin C 500mg
- Lifestyle Intervention
Treatment groups
120 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov